David Shaw’s Redhill Biopharma RDHL Stock Holding History

David Shaw’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-14	Closed	-$113K	–	3824
2019 Q1	$113K	Sell	14 -19	-58%	-$150K	﹤0.01%	3474
2018 Q4	$186K	Buy	+33	New	+$253K	﹤0.01%	3560

Other funds holding RDHL

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

David Shaw's RDHL Position: Q2 2019 in Review

David Shaw sold out of Redhill Biopharma (RDHL) in Q2 2019, closing a stake of 14 shares — an estimated $113K sold.

David Shaw first reported a position in RDHL in Q4 2018 and held it in 2 quarters. The position peaked at $186K in Q4 2018. 34 funds tracked by Wall St. Rank hold RDHL as of Q2 2019.

David Shaw reported no remaining Redhill Biopharma position as of Q2 2019 after selling out during the quarter.
David Shaw sold 14 Redhill Biopharma shares in Q2 2019, an estimated $113K.
David Shaw first reported a position in Redhill Biopharma in Q4 2018 and held it in 2 quarters.
David Shaw's Redhill Biopharma position peaked at $186K in Q4 2018.
34 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2019.

Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.